Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate Addiction, SMA-167

First Page		Document Content
Date: 2013-10-29 08:32:29 Buprenorphine Methadone Opioid dependence Controlled Substances Act Notification system Narcotic Drug Enforcement Administration Opioid Drug Addiction Treatment Act Chemistry Drug rehabilitation Organic chemistry		Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate Addiction, SMA-167 Add to Reading List Source URL: www.naabt.org Download Document from Source Website File Size: 302,46 KB Share Document on Facebook

	The Opioid Crisis: What You Need to Know The opioid crisis has swept across the nation at an alarming rate. Drug abuse, dependence, and overdose are issues that affect the lives of millions of Americans. Given the sever DocID: 1vrfi - View Document
	J Ayub Med Coll Abbottabad 2008;A NEW AND NOVEL TREATMENT OF OPIOID DEPENDENCE: NIGELLA SATIVA 500 mg. Sibghatullah Sangi, Shahida P. Ahmed, Muhammad Aslam Channa*, Muhammad Ashfaq†, Shah Murad Mastoi†† DocID: 1vqF5 - View Document
	CLIENT BULLETIN Measuring Buprenorphine and Norbuprenorphine in Urine Buprenorphine is used as a replacement therapy in the treatment of opioid dependence and as an analgesic. This medication also has the potential for DocID: 1vgU3 - View Document
	The Opioid Crisis: What You Need to Know The opioid crisis has swept across the nation at an alarming rate. Drug abuse, dependence, and overdose are issues that affect the lives of millions of Americans. Given the sever DocID: 1vdc1 - View Document
	SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may adjust your trea DocID: 1uBp8 - View Document